Effects of a long-acting angiotensin-converting enzyme inhibitor, imidapril, on the lower limit of cerebral blood flow autoregulation in hypertensive rats

Hong Cai, Hiroshi Yao, Setsuro Ibayashi, Guoping Zhao, Takanari Kitazono, Tetsuhiko Nagao, Masatoshi Fujishima

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The objective of the present study was to examine the effects of a long-acting angiotensin converting enzyme inhibitor, imidapril ((4S)-1-methyl-3-{(2S)-2-[N-(1S)-1-ethoxycarbonyl-3-phenylpropyl) amino] propionyl}-2-oxoimidazolidine-4-carboxylic acid hydrochloride), for 7 days on the cerebral blood flow autoregulatory response to hypotension in hypertensive rats. We measured the cerebral blood now at rest and during hemorrhagic hypotension, using laser-Doppler flowmetry. At the same time, the absolute baseline cerebral blood now values in the parietal cortex were quantified with the hydrogen clearance method. After administration of imidapril at a dose of 5 mg/kg/day for 7 days, the resting value of mean arterial blood pressure was significantly decreased by 25 mm Hg (P < 0.001), cerebral vascular resistance was lowered by 14.4% (P < 0.05) and the lower limit of cerebral blood flow autoregulation was shifted to a lower level, 106 ± 11 mm Hg (mean ± S.D.), from 137 ± 8 mm Hg in the control group (P < 0.001), while resting cerebral blood flow remained unchanged. The present results demonstrated that imidapril preserves cerebral blood flow and significantly shifts the lower limit of cerebral autoregulation towards lower blood pressure levels.

Original languageEnglish
Pages (from-to)73-77
Number of pages5
JournalEuropean Journal of Pharmacology
Volume341
Issue number1
DOIs
Publication statusPublished - Jan 2 1998

Fingerprint

Cerebrovascular Circulation
Angiotensin-Converting Enzyme Inhibitors
Homeostasis
Hypotension
Arterial Pressure
Parietal Lobe
Laser-Doppler Flowmetry
Vascular Resistance
Hydrogen
Blood Pressure
Control Groups
imidapril

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Effects of a long-acting angiotensin-converting enzyme inhibitor, imidapril, on the lower limit of cerebral blood flow autoregulation in hypertensive rats. / Cai, Hong; Yao, Hiroshi; Ibayashi, Setsuro; Zhao, Guoping; Kitazono, Takanari; Nagao, Tetsuhiko; Fujishima, Masatoshi.

In: European Journal of Pharmacology, Vol. 341, No. 1, 02.01.1998, p. 73-77.

Research output: Contribution to journalArticle

Cai, Hong ; Yao, Hiroshi ; Ibayashi, Setsuro ; Zhao, Guoping ; Kitazono, Takanari ; Nagao, Tetsuhiko ; Fujishima, Masatoshi. / Effects of a long-acting angiotensin-converting enzyme inhibitor, imidapril, on the lower limit of cerebral blood flow autoregulation in hypertensive rats. In: European Journal of Pharmacology. 1998 ; Vol. 341, No. 1. pp. 73-77.
@article{8c66c1038ebd4a84b35e316cd2629815,
title = "Effects of a long-acting angiotensin-converting enzyme inhibitor, imidapril, on the lower limit of cerebral blood flow autoregulation in hypertensive rats",
abstract = "The objective of the present study was to examine the effects of a long-acting angiotensin converting enzyme inhibitor, imidapril ((4S)-1-methyl-3-{(2S)-2-[N-(1S)-1-ethoxycarbonyl-3-phenylpropyl) amino] propionyl}-2-oxoimidazolidine-4-carboxylic acid hydrochloride), for 7 days on the cerebral blood flow autoregulatory response to hypotension in hypertensive rats. We measured the cerebral blood now at rest and during hemorrhagic hypotension, using laser-Doppler flowmetry. At the same time, the absolute baseline cerebral blood now values in the parietal cortex were quantified with the hydrogen clearance method. After administration of imidapril at a dose of 5 mg/kg/day for 7 days, the resting value of mean arterial blood pressure was significantly decreased by 25 mm Hg (P < 0.001), cerebral vascular resistance was lowered by 14.4{\%} (P < 0.05) and the lower limit of cerebral blood flow autoregulation was shifted to a lower level, 106 ± 11 mm Hg (mean ± S.D.), from 137 ± 8 mm Hg in the control group (P < 0.001), while resting cerebral blood flow remained unchanged. The present results demonstrated that imidapril preserves cerebral blood flow and significantly shifts the lower limit of cerebral autoregulation towards lower blood pressure levels.",
author = "Hong Cai and Hiroshi Yao and Setsuro Ibayashi and Guoping Zhao and Takanari Kitazono and Tetsuhiko Nagao and Masatoshi Fujishima",
year = "1998",
month = "1",
day = "2",
doi = "10.1016/S0014-2999(97)01459-3",
language = "English",
volume = "341",
pages = "73--77",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Effects of a long-acting angiotensin-converting enzyme inhibitor, imidapril, on the lower limit of cerebral blood flow autoregulation in hypertensive rats

AU - Cai, Hong

AU - Yao, Hiroshi

AU - Ibayashi, Setsuro

AU - Zhao, Guoping

AU - Kitazono, Takanari

AU - Nagao, Tetsuhiko

AU - Fujishima, Masatoshi

PY - 1998/1/2

Y1 - 1998/1/2

N2 - The objective of the present study was to examine the effects of a long-acting angiotensin converting enzyme inhibitor, imidapril ((4S)-1-methyl-3-{(2S)-2-[N-(1S)-1-ethoxycarbonyl-3-phenylpropyl) amino] propionyl}-2-oxoimidazolidine-4-carboxylic acid hydrochloride), for 7 days on the cerebral blood flow autoregulatory response to hypotension in hypertensive rats. We measured the cerebral blood now at rest and during hemorrhagic hypotension, using laser-Doppler flowmetry. At the same time, the absolute baseline cerebral blood now values in the parietal cortex were quantified with the hydrogen clearance method. After administration of imidapril at a dose of 5 mg/kg/day for 7 days, the resting value of mean arterial blood pressure was significantly decreased by 25 mm Hg (P < 0.001), cerebral vascular resistance was lowered by 14.4% (P < 0.05) and the lower limit of cerebral blood flow autoregulation was shifted to a lower level, 106 ± 11 mm Hg (mean ± S.D.), from 137 ± 8 mm Hg in the control group (P < 0.001), while resting cerebral blood flow remained unchanged. The present results demonstrated that imidapril preserves cerebral blood flow and significantly shifts the lower limit of cerebral autoregulation towards lower blood pressure levels.

AB - The objective of the present study was to examine the effects of a long-acting angiotensin converting enzyme inhibitor, imidapril ((4S)-1-methyl-3-{(2S)-2-[N-(1S)-1-ethoxycarbonyl-3-phenylpropyl) amino] propionyl}-2-oxoimidazolidine-4-carboxylic acid hydrochloride), for 7 days on the cerebral blood flow autoregulatory response to hypotension in hypertensive rats. We measured the cerebral blood now at rest and during hemorrhagic hypotension, using laser-Doppler flowmetry. At the same time, the absolute baseline cerebral blood now values in the parietal cortex were quantified with the hydrogen clearance method. After administration of imidapril at a dose of 5 mg/kg/day for 7 days, the resting value of mean arterial blood pressure was significantly decreased by 25 mm Hg (P < 0.001), cerebral vascular resistance was lowered by 14.4% (P < 0.05) and the lower limit of cerebral blood flow autoregulation was shifted to a lower level, 106 ± 11 mm Hg (mean ± S.D.), from 137 ± 8 mm Hg in the control group (P < 0.001), while resting cerebral blood flow remained unchanged. The present results demonstrated that imidapril preserves cerebral blood flow and significantly shifts the lower limit of cerebral autoregulation towards lower blood pressure levels.

UR - http://www.scopus.com/inward/record.url?scp=0032472363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032472363&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(97)01459-3

DO - 10.1016/S0014-2999(97)01459-3

M3 - Article

VL - 341

SP - 73

EP - 77

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -